×

Enterprise Innovation

  • Maddie Moate makes a cloud controlled Graffiti Artist with the help of expert Jeff Gough.

  • Xvela is the world's first cloud-based vessel stowage and collaboration platform for ocean carriers and terminal operators.

  • London wine merchant Friarwood is looking to steal a march on competitors by cloud connecting a successful but antiquated business.

  • Mercedes is developing the next breed of commercial vehicles with their very own delivery drones, robots and revolutionary loading bay.

  • British company Stahler has developed a breakthrough biometric device that allows people to pay using their finger.

  • Maddie Moate makes a cloud connected trike with the help of expert Daniel Sikar.

  • Maddie Moate makes a cloud controlled Piggy Bank with the help of expert Josh Bannerman.

  • Cydar EV provides surgeons with a detailed 3D augmented reality view of anatomy.

  • Chrono Therapeutics is developing a new smart device that administers nicotine through the skin to help smokers quit.

  • A British start up called CERA is providing an on-demand social care platform.

  • Maddie Moate makes a cloud connected pill dispenser with the help of expert Wojtek Siudziński.

  • The team that delivered the video content for the opening ceremony of the 2012 Olympics have adapted Paul Auster's City of Glass for the stage.

  • With his work "Voices without borders" violinist Pierre Lebaron is allowing the audience to influence his performance through the cloud.

  • Technology and the Cloud are shifting the way some artists create and present their work.

  • March 30- The No. 1 U.S. wireless carrier Verizon Communications Inc has been buying streaming rights from television network owners ahead of a nationwide launch of an online TV service, according to people familiar with the matter. Verizon plans to sell a package with dozens of channels this year, the sources told Reuters. The news was first reported by Bloomberg.

  • UK- based Oxford BioMedica's shares get a lift. ZURICH, March 30- A new leukaemia treatment from Novartis for children and young adults will get priority review from the U.S. Food and Drug Administration, putting the Swiss drugmaker ahead of rivals working on similar cancer therapies. The FDA's announcement late Wednesday means the regulator plans to take...

  • *UK- based Oxford BioMedica's shares get a lift. ZURICH, March 30- A new leukemia treatment from Novartis for children and young adults will get priority review from the U.S. Food and Drug Administration, putting the Swiss drugmaker ahead of rivals working on similar cancer therapies. The FDA's announcement late Wednesday means the regulator plans to take action...

  • Analyst: The world is becoming a computer

    Hans Tung, Managing Partner at GGV Capital, and Brian White, Drexel Hamilton Analyst, weigh in on Samsung unveiling the Galaxy S8.

  • March 28- The two buyout firms that own Pharmaceutical Product Development LLC are in advanced talks to sell some of their stakes in the U.S. clinical trials firm at a price that would value the entire company at more than $9 billion, including debt, people familiar with the matter said. Carlyle and Hellman& Friedman are in talks to sell minority stakes in PPD to...

  • Pres Trump: Administration ending the 'war on coal'

    Karen Harbert, U.S. Chamber of Commerce Energy Institute president & CEO, weighs in on President Trump signing a new energy executive order.